Nifty

:

16352.45

Sensex

:

54884.66

182.30 (1.13%)
632.13 (1.17%)

Login

Nifty
Sensex

:
:

16352.45
54884.66

182.30 (1.13%)
632.13 (1.17%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

76/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

300.30

26-May-2022

Open
High
Low
Previous Close

283.80
306.30
274.00
285.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

46122
134.02
369.00
96.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

783.84
31.78
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

730.40
0.33%
6.36

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.63
5.49
4.05

EBITDA CAGR (%)

10 Years
5 Years
3 Years

1.40
27.02
15.36

PAT CAGR (%)

10 Years
5 Years
3 Years

8.62
7.54
33.19

P:E (Median)

8 Years
5 Years
3 Years

18.50
11.62
15.36

P:BV (Average)

8 Years
5 Years
3 Years

2.58
2.58
2.58

EV:EBITDA (Average)

8 Years
5 Years
3 Years

274.44
433.89
8.99

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 54.47 57.10 -4.61% 59.49 56.35 5.57% 60.00 31.65 89.57% 42.84 57.10 -24.97%
Expenses 48.86 50.62 -3.48% 49.21 51.52 -4.48% 50.72 29.01 74.84% 37.72 50.62 -25.48%
EBITDA 5.61 6.48 -13.43% 10.28 4.83 112.84% 9.27 2.65 249.81% 5.12 6.48 -20.99%
EBIDTM 10.30% 11.35% 17.28% 8.58% 15.46% 8.36% 11.94% 11.35%
Other Income 1.95 0.53 267.92% 0.29 0.41 -29.27% 0.82 0.78 5.13% 2.66 0.53 401.89%
Interest 0.06 0.14 -57.14% 0.06 0.12 -50.00% 0.11 0.13 -15.38% 0.13 0.14 -7.14%
Depreciation 0.37 0.27 37.04% 0.23 0.28 -17.86% 0.28 0.28 0.00% 0.26 0.27 -3.70%
PBT 7.14 6.61 8.02% 10.28 4.85 111.96% 9.71 3.02 221.52% 7.38 6.61 11.65%
Tax 1.73 1.18 46.61% 2.97 0.85 249.41% 2.86 0.51 460.78% 2.28 1.18 93.22%
PAT 5.41 5.43 -0.37% 7.31 4.01 82.29% 6.85 2.52 171.83% 5.10 5.43 -6.08%
PATM 9.93% 9.51% 12.28% 7.11% 11.42% 7.96% 11.90% 9.51%
EPS 2.06 2.07 -0.48% 2.79 1.53 82.35% 2.61 0.96 171.88% 1.95 2.07 -5.80%

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 216.80 187.95 158.57 166.83 126.53 143.87 143.49 138.15 143.85 166.46 176.51 Net Sales Growth 7.22% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% -13.58% -5.69% Cost Of Goods Sold 86.86 80.78 56.19 72.85 61.11 58.95 59.13 68.68 64.71 86.16 84.54 Gross Profit 129.94 107.17 102.38 93.98 65.42 84.92 84.36 69.47 79.14 80.30 91.97 GP Margin 59.93% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% 48.24% 52.10% Total Expenditure 186.51 168.87 150.04 157.49 137.64 138.10 131.68 129.42 133.17 156.41 159.90 Power & Fuel Cost - 0.52 0.76 1.41 1.00 2.12 2.26 1.77 2.23 2.55 2.52 % Of Sales - 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% 1.53% 1.43% Employee Cost - 53.98 50.37 46.61 41.88 40.95 37.84 32.11 37.83 37.25 36.51 % Of Sales - 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% 22.38% 20.68% Manufacturing Exp. - 0.62 0.51 0.73 0.96 1.34 1.70 1.01 1.57 2.01 1.04 % Of Sales - 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% 1.21% 0.59% General & Admin Exp. - 18.75 23.55 19.03 16.31 16.44 13.61 9.64 8.55 8.87 8.87 % Of Sales - 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% 5.33% 5.03% Selling & Distn. Exp. - 12.99 17.45 13.20 11.25 13.74 12.96 11.53 14.36 15.45 20.28 % Of Sales - 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% 9.28% 11.49% Miscellaneous Exp. - 1.22 1.20 3.66 5.14 4.56 4.19 4.67 3.92 4.11 20.28 % Of Sales - 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% 2.47% 3.48% EBITDA 30.28 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 10.05 16.61 EBITDA Margin 13.97% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% 6.04% 9.41% Other Income 5.72 4.39 2.53 1.43 0.46 0.47 0.66 0.11 0.06 0.32 0.37 Interest 0.36 0.51 0.51 0.75 0.66 2.64 5.30 4.46 5.38 5.13 4.36 Depreciation 1.14 1.09 1.13 1.02 0.32 1.99 3.09 2.71 2.83 2.71 2.54 PBT 34.51 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 2.54 10.09 Tax 9.84 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 0.70 2.63 Tax Rate 28.51% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% 27.56% 26.07% PAT 24.67 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 PAT before Minority Interest 24.67 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.38% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% 1.10% 4.23% PAT Growth 41.86% 116.77% 9.00% - - 264.92% 177.78% -44.81% 15.85% -75.47% EPS 9.42 6.51 3.00 2.76 -4.41 4.53 1.24 0.45 0.81 0.70 2.85

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 121.93 111.03 104.47 98.05 109.91 98.36 95.43 98.59 98.37 98.47 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 108.83 97.93 91.37 84.95 96.81 85.27 82.33 85.49 85.27 85.37 Non-Current Liabilities 1.88 3.09 3.12 3.19 3.26 3.61 3.60 4.08 4.50 4.25 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 0.27 Long Term Provisions 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 40.40 34.57 28.19 28.58 29.44 57.31 55.19 53.58 50.13 53.38 Trade Payables 18.05 11.71 11.86 9.09 8.98 9.73 7.87 5.08 6.51 8.14 Other Current Liabilities 10.89 8.16 5.60 6.10 7.12 6.61 6.24 5.48 3.99 4.79 Short Term Borrowings 6.79 6.40 3.79 8.30 7.93 38.49 39.31 35.96 33.09 34.62 Short Term Provisions 4.67 8.30 6.95 5.09 5.41 2.48 1.77 7.06 6.55 5.83 Total Liabilities 164.21 148.69 135.78 129.82 142.61 159.28 154.22 156.25 153.00 156.10 Net Block 25.72 24.44 21.64 21.32 21.59 51.61 51.96 56.41 58.35 59.15 Gross Block 60.12 58.17 55.00 53.66 52.88 90.35 87.61 87.01 85.75 83.44 Accumulated Depreciation 34.40 33.74 33.36 32.34 31.28 38.74 35.65 30.60 27.41 24.29 Non Current Assets 43.73 52.39 38.23 35.20 32.50 58.32 58.43 64.94 66.46 65.17 Capital Work in Progress 0.00 1.90 3.95 3.04 0.00 0.00 0.00 2.35 2.33 0.93 Non Current Investment 12.06 11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.66 14.53 12.63 10.84 10.90 6.71 6.47 6.19 5.78 5.09 Other Non Current Assets 0.29 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 120.48 96.31 97.56 94.61 110.11 100.96 95.79 91.31 86.54 90.93 Current Investments 3.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 29.72 29.32 32.69 51.43 47.62 39.84 33.06 30.59 30.07 35.22 Sundry Debtors 12.66 21.45 20.75 25.15 39.41 41.69 44.89 45.22 42.20 42.31 Cash & Bank 60.23 40.49 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 Other Current Assets 14.61 0.52 0.94 0.24 3.03 3.90 2.83 2.90 3.93 3.53 Short Term Loans & Adv. 14.34 4.52 4.64 3.27 2.80 3.90 2.83 2.90 3.93 3.53 Net Current Assets 80.08 61.74 69.37 66.03 80.68 43.65 40.60 37.73 36.41 37.55 Total Assets 164.21 148.70 135.79 129.81 142.61 159.28 154.22 156.25 153.00 156.10

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 7.52 12.05 7.08 PBT 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 2.54 10.09 Adjustment -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 8.15 7.52 6.52 Changes in Working Capital 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 -2.65 2.50 -7.51 Cash after chg. in Working capital 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 8.02 12.56 9.10 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 -0.51 -0.51 -2.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 -3.39 -4.94 Net Fixed Assets -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 -1.28 -3.71 -5.31 Net Investments -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 0.07 0.32 0.37 Cash from Financing Activity -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 -8.19 0.41 Net Cash Inflow / Outflow 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 2.26 0.46 2.56 Opening Cash & Equivalents 39.81 40.82 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 Closing Cash & Equivalent 58.94 39.81 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 43.55 39.39 36.89 34.43 38.96 34.55 33.43 32.86 32.63 32.52 ROA 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% 1.19% 5.09% ROE 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% 2.15% 9.07% ROCE 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% 6.42% 12.68% Fixed Asset Turnover 3.18 2.80 3.07 2.38 2.03 1.62 1.59 1.68 2.01 2.22 Receivable days 33.13 48.57 50.22 93.07 102.03 109.58 118.23 109.72 90.52 86.16 Inventory Days 57.34 71.38 92.03 142.78 110.02 92.27 83.52 76.13 69.93 58.36 Payable days 67.24 34.46 31.91 27.07 22.17 21.36 15.26 9.95 12.35 10.51 Cash Conversion Cycle 23.23 85.49 110.33 208.78 189.88 180.49 186.49 175.90 148.10 134.00 Total Debt/Equity 0.06 0.06 0.04 0.09 0.08 0.43 0.45 0.42 0.39 0.41 Interest Cover 43.59 19.31 13.08 -16.69 6.44 1.77 1.37 1.47 1.49 3.32

Top Investors:

si investments and broking private limited

sanjiv kumar dudeja

lincoln p coelho

rajasthan global securities private limited

Annual Reports:

News Update:

Jagsonpal Pharmaceuticals enters into agreement with Suvinys Developers
18th Feb 2022, 11:37 AM

Suvinys Developers will supply Dydrogesterone to Jagsonpal Pharmaceuticals as per the terms and conditions as mentioned in the agreement
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback